Citations (87)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Farshid Zandsalimi, Sam Talaei, Mehdi Noormohammad Ahari, Shahin Aghamiri, Pourya Raee, Soheil Roshanzamiri, Fatemeh Yarian, Mojgan Bandehpour & Zeinab Zohrab Zadeh. (2020) Antimicrobial peptides: a promising strategy for lung cancer drug discovery?. Expert Opinion on Drug Discovery 15:11, pages 1343-1354.
Read now
Read now
Marta Di Pasquale, Stefano Aliberti, Marco Mantero, Andrea Gramegna & Francesco Blasi. (2020) Pharmacotherapeutic management of bronchial infections in adults: non-cystic fibrosis bronchiectasis and chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 21:16, pages 1975-1990.
Read now
Read now
Ana Motos, Hua Yang, Minlan Yang & Antoni Torres. (2019) Perspectives on synthetic pharmacotherapy for the treatment of nosocomial pneumonia. Expert Opinion on Pharmacotherapy 20:12, pages 1439-1448.
Read now
Read now
Articles from other publishers (84)
Xiaotong Gu, Weijin Chen, Ting Guo, Xiaohong Chang, Shenyan Zhang, Bingfang Bai & Shutao Ma. (2024) A novel synthetic method for backbone-cyclized polypeptide POL7080 with the help of hydrophobic-support materials. Organic & Biomolecular Chemistry.
Crossref
Crossref
Matteo Bassetti, Nadia Castaldo, Alberto Fantin, Daniele Roberto Giacobbe & Antonio Vena. (2023) Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives. Current Opinion in Infectious Diseases 36:6, pages 615-622.
Crossref
Crossref
Ursula Theuretzbacher, Benjamin Blasco, Maëlle Duffey & Laura J. V. Piddock. (2023) Unrealized targets in the discovery of antibiotics for Gram-negative bacterial infections. Nature Reviews Drug Discovery 22:12, pages 957-975.
Crossref
Crossref
Xiaoya Wei, Jiacong Gao, Congjuan Xu, Xiaolei Pan, Yongxin Jin, Fang Bai, Zhihui Cheng, Iain L. Lamont, Daniel Pletzer & Weihui Wu. (2023)
Murepavadin induces envelope stress response and enhances the killing efficacies of β-lactam antibiotics by impairing the outer membrane integrity of
Pseudomonas aeruginosa
. Microbiology Spectrum 11:5.
Crossref
Crossref
Akshay Sabnis & Andrew M. Edwards. (2023) Lipopolysaccharide as an antibiotic target. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1870:7, pages 119507.
Crossref
Crossref
Jhajan Lal, Grace Kaul, Abdul Akhir, Deepanshi Saxena, Harshita Dubkara, Shashank Shekhar, Sidharth Chopra & Damodara N. Reddy. (2023) β-Turn editing in Gramicidin S: Activity impact on replacing proline α-carbon with stereodynamic nitrogen. Bioorganic Chemistry 138, pages 106641.
Crossref
Crossref
Christine Esposito, Martin Kamper, Jessica Trentacoste, Susan Galvin, Halie Pfister & Janice Wang. (2023) Advances in the Cystic Fibrosis Drug Development Pipeline. Life 13:9, pages 1835.
Crossref
Crossref
Manuela Machado, Sara Silva & Eduardo M. Costa. (2023) Are Antimicrobial Peptides a 21st-Century Solution for Atopic Dermatitis?. International Journal of Molecular Sciences 24:17, pages 13460.
Crossref
Crossref
Justin R Randall, Kyra E Groover, Angela C O'Donnell, Joseph M Garza, T Jeffrey Cole & Bryan W Davies. (2023) Adapting antibacterial display to identify serum-active macrocyclic peptide antibiotics. PNAS Nexus 2:8.
Crossref
Crossref
Lia Costa, Emília Sousa & Carla Fernandes. (2023) Cyclic Peptides in Pipeline: What Future for These Great Molecules?. Pharmaceuticals 16:7, pages 996.
Crossref
Crossref
V. N. Safronova, I. A. Bolosov, P. V. Panteleev, S. V. Balandin & T. V. Ovchinnikova. (2023) Therapeutic Potential and Prospects of Application of Peptides in the Era of the Global Spread of Antibiotic Resistance. Russian Journal of Bioorganic Chemistry 49:3, pages 435-447.
Crossref
Crossref
Justin R. Randall, Xun Wang, Kyra E. Groover, Angela C. O'Donnell & Bryan W. Davies. (2023) Using display technologies to identify macrocyclic peptide antibiotics. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1870:5, pages 119473.
Crossref
Crossref
Qian Xu, Min Guo & Feiyuan Yu. (2023) β-Barrel Assembly Machinery (BAM) Complex as Novel Antibacterial Drug Target. Molecules 28:9, pages 3758.
Crossref
Crossref
Moamen M. Elmassry, Jane A. Colmer-Hamood, Jonathan Kopel, Michael J. San Francisco & Abdul N. Hamood. (2023) Anti-Pseudomonas aeruginosa Vaccines and Therapies: An Assessment of Clinical Trials. Microorganisms 11:4, pages 916.
Crossref
Crossref
Ali Javed, Cornelis J. Slingerland, Thomas M. Wood, Nathaniel I. Martin, Femke Broere, Markus H. Weingarth & Edwin J. A. Veldhuizen. (2023) Chimeric Peptidomimetic Antibiotic Efficiently Neutralizes Lipopolysaccharides (LPS) and Bacteria-Induced Activation of RAW Macrophages. ACS Infectious Diseases 9:3, pages 518-526.
Crossref
Crossref
Danni Li & Elena K. Schneider-Futschik. (2023) Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis. Antibiotics 12:3, pages 484.
Crossref
Crossref
Jingwen Lyu, Huimin Chen, Jinwei Bao, Suling Liu, Yiling Chen, Xuxia Cui, Caixia Guo, Bing Gu & Lu Li. (2023) Clinical Distribution and Drug Resistance of Pseudomonas aeruginosa in Guangzhou, China from 2017 to 2021. Journal of Clinical Medicine 12:3, pages 1189.
Crossref
Crossref
Paola Sperandeo, Alessandra M. Martorana, Marta Zaccaria & Alessandra Polissi. (2023) Targeting the LPS export pathway for the development of novel therapeutics. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1870:2, pages 119406.
Crossref
Crossref
Frida Svanberg Frisinger, Bimal Jana, Juan C Ortiz-Marquez, Tim van Opijnen, Stefano Donadio & Luca Guardabassi. (2023)
LptD depletion disrupts morphological homeostasis and upregulates carbohydrate metabolism in
Escherichia coli
. FEMS Microbes 4.
Crossref
Crossref
Justin R. Randall, Cory D. DuPai, T. Jeffrey Cole, Gillian DavidsonKyra E. Groover, Sabrina L. Slater, Despoina A. I. Mavridou, Claus O. Wilke & Bryan W. Davies. (2023) Designing and identifying β-hairpin peptide macrocycles with antibiotic potential. Science Advances 9:2.
Crossref
Crossref
Sebastian Walesch, Joy Birkelbach, Gwenaëlle Jézéquel, F P Jake Haeckl, Julian D Hegemann, Thomas Hesterkamp, Anna K H Hirsch, Peter Hammann & Rolf Müller. (2022) Fighting antibiotic resistance—strategies and (pre)clinical developments to find new antibacterials. EMBO reports 24:1.
Crossref
Crossref
Jhajan Lal, Gurudayal Prajapati, Rachana Meena, Ruchir Kant, Ravi Sankar Ampapathi & Damodara N. Reddy. (2022) Influence of Proline Chirality on Neighbouring Azaproline Residue Stereodynamic Nitrogen Preorganization. Chemistry – An Asian Journal 18:1.
Crossref
Crossref
Alvaro Mourenza, Rajasekaran Ganesan & Julio A. Camarero. (2023)
Resistance is futile: targeting multidrug-resistant bacteria with
de novo
Cys-rich cyclic polypeptides
. RSC Chemical Biology.
Crossref
Crossref
Grace Kaul, Manjulika Shukla, Isha Soni, Vaishnavi Veerareddy, Ravi Akunuri Kumar, Arunava Dasgupta, Nanduri Srinivas & Sidharth Chopra. 2023. Recent Advances in Pharmaceutical Innovation and Research. Recent Advances in Pharmaceutical Innovation and Research
713
747
.
Shian Lai, Quan Zhang & Lin Jin. (2022) Natural and Man-Made Cyclic Peptide-Based Antibiotics. Antibiotics 12:1, pages 42.
Crossref
Crossref
Jasminka Talapko, Tomislav Meštrović, Martina Juzbašić, Matej Tomas, Suzana Erić, Lorena Horvat Aleksijević, Sanja Bekić, Dragan Schwarz, Suzana Matić, Marijana Neuberg & Ivana Škrlec. (2022) Antimicrobial Peptides—Mechanisms of Action, Antimicrobial Effects and Clinical Applications. Antibiotics 11:10, pages 1417.
Crossref
Crossref
Zhuowen Hao, Renxin Chen, Chen Chai, Yi Wang, Tianhong Chen, Hanke Li, Yingkun Hu, Qinyu Feng & Jingfeng Li. (2022) Antimicrobial peptides for bone tissue engineering: Diversity, effects and applications. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Akshita Thakur, Akanksha Sharma, Hema K. Alajangi, Pradeep Kumar Jaiswal, Yong-beom Lim, Gurpal Singh & Ravi Pratap Barnwal. (2022) In pursuit of next-generation therapeutics: Antimicrobial peptides against superbugs, their sources, mechanism of action, nanotechnology-based delivery, and clinical applications. International Journal of Biological Macromolecules 218, pages 135-156.
Crossref
Crossref
Mukesh Kumar Sharma, Moh. Rizvan, Nayeem Ahmad, Puneet Jain & Mohan Kumar. (2022) Treatment of MDR Gram-Negative Bacteria Infections: Ongoing and Prospective. Journal of Pure and Applied Microbiology 16:3, pages 1575-1589.
Crossref
Crossref
Sébastien Reig, Audrey Le Gouellec & Sophie Bleves. (2022) What Is New in the Anti–Pseudomonas aeruginosa Clinical Development Pipeline Since the 2017 WHO Alert?. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
María Escobar‐Salom, Gabriel Torrens, Elena Jordana‐Lluch, Antonio Oliver & Carlos Juan. (2022)
Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug‐resistant
Gram
‐negatives
. Biological Reviews 97:3, pages 1005-1037.
Crossref
Crossref
Neha K. Prasad, Ian B. Seiple, Ryan T. Cirz & Oren S. Rosenberg. (2022) Leaks in the Pipeline: a Failure Analysis of Gram-Negative Antibiotic Development from 2010 to 2020. Antimicrobial Agents and Chemotherapy 66:5.
Crossref
Crossref
Vincent Faugeras, Olivier Duclos, Didier Bazile & Abdou Rachid Thiam. (2022) Impact of Cyclization and Methylation on Peptide Penetration through Droplet Interface Bilayers. Langmuir 38:18, pages 5682-5691.
Crossref
Crossref
Vishal A. Verma, Lan Wang, Sharada S. Labadie, Jun Liang, Benjamin D. Sellers, Jian Wang, Liting Dong, Qiuyue Wang, Shuang Zhang, Zhongya Xu, Yexia Zhang, Yanan Niu, Xinxin Wang, John Wai, Michael F. T. Koehler, Huiyong Hu, Mary Kate Alexander, Mireille Nishiyama, Anh Miu, Yiming Xu, Jodie Pang, Anand K. Katakam, Michael Reichelt, Cary D. Austin, Hoangdung Ho, Jian Payandeh & Christopher M. Koth. (2022) Discovery of Inhibitors of the Lipopolysaccharide Transporter MsbA: From a Screening Hit to Potent Wild-Type Gram-Negative Activity. Journal of Medicinal Chemistry 65:5, pages 4085-4120.
Crossref
Crossref
Angela L. Woods, David Parker, Meir M. Glick, Yunshan Peng, Francois Lenoir, Evan Mulligan, Vincent Yu, Grazia Piizzi, Troy Lister, Maria-Dawn Lilly, JoAnn Dzink-Fox, Johanna M. Jansen, Neil S. Ryder, Charles R. Dean & Thomas M. Smith. (2022)
High-Throughput Screen for Inhibitors of
Klebsiella pneumoniae
Virulence Using a
Tetrahymena pyriformis
Co-Culture Surrogate Host Model
. ACS Omega 7:6, pages 5401-5414.
Crossref
Crossref
Justin R. Randall, Gillian Davidson, Renee M. Fleeman, Santos A. Acosta, Ian M. Riddington, T. Jeffrey Cole, Cory D. DuPai & Bryan W. Davies. (2022) Synthetic antibacterial discovery of symbah-1, a macrocyclic β-hairpin peptide antibiotic. iScience 25:1, pages 103611.
Crossref
Crossref
Yuncheng Wang, Rachel Yoon Kyung Chang, Warwick J. Britton & Hak-Kim Chan. (2022) Advances in the development of antimicrobial peptides and proteins for inhaled therapy. Advanced Drug Delivery Reviews 180, pages 114066.
Crossref
Crossref
Loretta Ferrera, Floriana Cappiello, Maria Rosa Loffredo, Elena Puglisi, Bruno Casciaro, Bruno Botta, Luis J. V. Galietta, Mattia Mori & Maria Luisa Mangoni. (2021) Esc peptides as novel potentiators of defective cystic fibrosis transmembrane conductance regulator: an unprecedented property of antimicrobial peptides. Cellular and Molecular Life Sciences 79:1.
Crossref
Crossref
Irfan Ahmad Khan. 2022. Beta-Lactam Resistance in Gram-Negative Bacteria. Beta-Lactam Resistance in Gram-Negative Bacteria
299
314
.
Karishma Biswas & Anirban Bhunia. 2022. Lipopolysaccharide Transport. Lipopolysaccharide Transport
211
231
.
Dipankar Chaudhuri, Rajasekaran Ganesan, Alicia Vogelaar, Mansour A. Dughbaj, Paul M. Beringer & Julio A. Camarero. (2021) Chemical Synthesis of a Potent Antimicrobial Peptide Murepavadin Using a Tandem Native Chemical Ligation/Desulfurization Reaction. The Journal of Organic Chemistry 86:21, pages 15242-15246.
Crossref
Crossref
Matteo Bassetti, Antonio Vena, Daniele Roberto Giacobbe & Nadia Castaldo. (2021) Management of Infections Caused by Multidrug-resistant Gram-negative Pathogens: Recent Advances and Future Directions. Archives of Medical Research 52:8, pages 817-827.
Crossref
Crossref
María Díez-Aguilar, Miquel Ekkelenkamp, María-Isabel Morosini, Natalia Huertas, Rosa del Campo, Javier Zamora, Ad C Fluit, Michael M Tunney, Daniel Obrecht, Francesca Bernardini & Rafael Cantón. (2021)
Anti-biofilm activity of murepavadin against cystic fibrosis
Pseudomonas aeruginosa
isolates
. Journal of Antimicrobial Chemotherapy 76:10, pages 2578-2585.
Crossref
Crossref
Thomas M. Wood, Cornelis J. Slingerland & Nathaniel I. Martin. (2021) A Convenient Chemoenzymatic Preparation of Chimeric Macrocyclic Peptide Antibiotics with Potent Activity against Gram-Negative Pathogens. Journal of Medicinal Chemistry 64:15, pages 10890-10899.
Crossref
Crossref
Aetas Amponnawarat, Chalatip Chompunud Na Ayudhya & Hydar Ali. (2021) Murepavadin, a Small Molecule Host Defense Peptide Mimetic, Activates Mast Cells via MRGPRX2 and MrgprB2. Frontiers in Immunology 12.
Crossref
Crossref
Frida Svanberg Frisinger, Bimal Jana, Stefano Donadio & Luca Guardabassi. (2021) In Silico Prediction and Prioritization of Novel Selective Antimicrobial Drug Targets in Escherichia coli. Antibiotics 10:6, pages 632.
Crossref
Crossref
María Díez-Aguilar, Marta Hernández-García, María-Isabel Morosini, Ad Fluit, Michael M Tunney, Natalia Huertas, Rosa del Campo, Daniel Obrecht, Francesca Bernardini, Miquel Ekkelenkamp & Rafael Cantón. (2021)
Murepavadin antimicrobial activity against and resistance development in cystic fibrosis
Pseudomonas aeruginosa
isolates
. Journal of Antimicrobial Chemotherapy 76:4, pages 984-992.
Crossref
Crossref
Gregory Upert, Anatol Luther, Daniel Obrecht & Philipp Ermert. (2021) Emerging peptide antibiotics with therapeutic potential. Medicine in Drug Discovery 9, pages 100078.
Crossref
Crossref
Qidi Kong & Yushe Yang. (2021) Recent advances in antibacterial agents. Bioorganic & Medicinal Chemistry Letters 35, pages 127799.
Crossref
Crossref
Gabrielle S. Dijksteel, Magda M. W. Ulrich, Esther Middelkoop & Bouke K. H. L. Boekema. (2021) Review: Lessons Learned From Clinical Trials Using Antimicrobial Peptides (AMPs). Frontiers in Microbiology 12.
Crossref
Crossref
Yuan Liu, Jingru Shi, Ziwen Tong, Yuqian Jia, Bingqing Yang & Zhiqiang Wang. (2021) The revitalization of antimicrobial peptides in the resistance era. Pharmacological Research 163, pages 105276.
Crossref
Crossref
Debabrata Ghosh Dastidar, Dipanjan Ghosh, Swarnasree Ghosh & Gopal Chakrabarti. 2021. Targeting Cellular Signalling Pathways in Lung Diseases. Targeting Cellular Signalling Pathways in Lung Diseases
847
902
.
Rachael E. Impey, Daniel A. Hawkins, J. Mark Sutton & Tatiana P. Soares da Costa. (2020) Overcoming Intrinsic and Acquired Resistance Mechanisms Associated with the Cell Wall of Gram-Negative Bacteria. Antibiotics 9:9, pages 623.
Crossref
Crossref
Boris Garber & Jonathan Glauser. (2020) Recent Developments in Infectious Disease Chemotherapy: Review for Emergency Department Practitioners 2020. Current Emergency and Hospital Medicine Reports 8:3, pages 116-121.
Crossref
Crossref
A. Provenzani, A. R. Hospodar, A. L. Meyer, D. Leonardi Vinci, E. Y. Hwang, C. M. Butrus & P. Polidori. (2020) Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents. International Journal of Clinical Pharmacy 42:4, pages 1016-1025.
Crossref
Crossref
David M. P. De Oliveira, Brian M. Forde, Timothy J. Kidd, Patrick N. A. Harris, Mark A. Schembri, Scott A. Beatson, David L. Paterson & Mark J. Walker. (2020) Antimicrobial Resistance in ESKAPE Pathogens. Clinical Microbiology Reviews 33:3.
Crossref
Crossref
Mark S. Butler & David L. Paterson. (2020) Antibiotics in the clinical pipeline in October 2019. The Journal of Antibiotics 73:6, pages 329-364.
Crossref
Crossref
Hugo Sámano-Sánchez & Toby J. Gibson. (2020) Mimicry of Short Linear Motifs by Bacterial Pathogens: A Drugging Opportunity. Trends in Biochemical Sciences 45:6, pages 526-544.
Crossref
Crossref
Karishma Biswas, Humaira Ilyas, Aritreyee Datta & Anirban Bhunia. (2020) NMR Assisted Antimicrobial Peptide Designing: Structure Based Modifications and Functional Correlation of a Designed Peptide VG16KRKP. Current Medicinal Chemistry 27:9, pages 1387-1404.
Crossref
Crossref
Yasunari Otsuka. (2020) Potent Antibiotics Active against Multidrug-Resistant Gram-Negative Bacteria. Chemical and Pharmaceutical Bulletin 68:3, pages 182-190.
Crossref
Crossref
Girish M. Bhopale. (2020) Antimicrobial Peptides: A Promising Avenue for Human Healthcare. Current Pharmaceutical Biotechnology 21:2, pages 90-96.
Crossref
Crossref
Craig R. MacNair, Caressa N. Tsai & Eric D. Brown. (2019) Creative targeting of the Gram‐negative outer membrane in antibiotic discovery. Annals of the New York Academy of Sciences 1459:1, pages 69-85.
Crossref
Crossref
Karl P. Lundquist & James C. Gumbart. (2020) Presence of substrate aids lateral gate separation in LptD. Biochimica et Biophysica Acta (BBA) - Biomembranes 1862:1, pages 183025.
Crossref
Crossref
Kate Watkins & Meera Unnikrishnan. 2020. Drug Discovery Targeting Drug-Resistant Bacteria. Drug Discovery Targeting Drug-Resistant Bacteria
249
272
.
Yu‐Xuan Ma, Chen‐Yu Wang, Yuan‐Yuan Li, Jing Li, Qian‐Qian Wan, Ji‐Hua Chen, Franklin R. Tay & Li‐Na Niu. (2019) Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections. Advanced Science 7:1.
Crossref
Crossref
Laura Carro. (2019) Recent Progress in the Development of Small-Molecule FtsZ Inhibitors as Chemical Tools for the Development of Novel Antibiotics. Antibiotics 8:4, pages 217.
Crossref
Crossref
Paola Sperandeo, Alessandra M. Martorana & Alessandra Polissi. (2019) The Lpt ABC transporter for lipopolysaccharide export to the cell surface. Research in Microbiology 170:8, pages 366-373.
Crossref
Crossref
Richard J Vickers, Matteo Bassetti, Cornelius J Clancy, Kevin W Garey, David E Greenberg, Minh-Hong Nguyen, David Roblin, Glenn S Tillotson & Mark H Wilcox. (2019) Combating resistance while maintaining innovation: the future of antimicrobial stewardship. Future Microbiology 14:15, pages 1331-1341.
Crossref
Crossref
Ian M Gould, Chathuri Gunasekera & Ali Khan. (2019) Antibacterials in the pipeline and perspectives for the near future. Current Opinion in Pharmacology 48, pages 69-75.
Crossref
Crossref
George H Talbot, Amanda Jezek, Barbara E Murray, Ronald N Jones, Richard H Ebright, Gerard J Nau, Keith A Rodvold, Jason G Newland & Helen W Boucher. (2019) The Infectious Diseases Society of America’s 10 × ’20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × ’20 a Possibility?. Clinical Infectious Diseases 69:1, pages 1-11.
Crossref
Crossref
J. C. Bader, E. A. Lakota, G. E. Dale, H. S. Sader, J. H. Rex, P. G. Ambrose & S. M. Bhavnani. (2019) Pharmacokinetic-Pharmacodynamic Evaluation of Ertapenem for Patients with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia. Antimicrobial Agents and Chemotherapy 63:6.
Crossref
Crossref
Manoj Jangra, Manpreet Kaur & Hemraj Nandanwar. (2019) In-vitro studies on a natural lantibiotic, paenibacillin: A new-generation antibacterial drug candidate to overcome multi-drug resistance. International Journal of Antimicrobial Agents 53:6, pages 838-843.
Crossref
Crossref
Matteo Bassetti, Maddalena Peghin, Antonio Vena & Daniele Roberto Giacobbe. (2019) Treatment of Infections Due to MDR Gram-Negative Bacteria. Frontiers in Medicine 6.
Crossref
Crossref
Helio S Sader, Paul R Rhomberg, Andrew S Fuhrmeister, Rodrigo E Mendes, Robert K Flamm & Ronald N Jones. (2019) Antimicrobial Resistance Surveillance and New Drug Development. Open Forum Infectious Diseases 6:Supplement_1, pages S5-S13.
Crossref
Crossref
M. J. Melchers, J. Teague, P. Warn, J. Hansen, F. Bernardini, A. Wach, D. Obrecht, G. E. Dale & J. W. Mouton. (2019) Pharmacokinetics and Pharmacodynamics of Murepavadin in Neutropenic Mouse Models. Antimicrobial Agents and Chemotherapy 63:3.
Crossref
Crossref
Kristina Klein, Michael S. Sonnabend, Lisa Frank, Karolin Leibiger, Mirita Franz-Wachtel, Boris Macek, Thomas Trunk, Jack C. Leo, Ingo B. Autenrieth, Monika Schütz & Erwin Bohn. (2019) Deprivation of the Periplasmic Chaperone SurA Reduces Virulence and Restores Antibiotic Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa. Frontiers in Microbiology 10.
Crossref
Crossref
John A. Robinson. (2019) Folded Synthetic Peptides and Other Molecules Targeting Outer Membrane Protein Complexes in Gram-Negative Bacteria. Frontiers in Chemistry 7.
Crossref
Crossref
Sandeep Nayar, Ashfaq Hasan, Pradyut Waghray, Srinivasan Ramananthan, Jaishid Ahdal & Rishi Jain. (2019) Management of community-acquired bacterial pneumonia in adults: Limitations of current antibiotics and future therapies. Lung India 36:6, pages 525.
Crossref
Crossref
Richard R. Watkins & David Van Duin. (2019) Current trends in the treatment of pneumonia due to multidrug-resistant Gram-negative bacteria. F1000Research 8, pages 121.
Crossref
Crossref
M. Bassetti, E. Righi & A. Carnelutti. 2019. Annual Update in Intensive Care and Emergency Medicine 2019. Annual Update in Intensive Care and Emergency Medicine 2019
477
495
.
Donghyeok Gang, Do Kim & Hee-Sung Park. (2018) Cyclic Peptides: Promising Scaffolds for Biopharmaceuticals. Genes 9:11, pages 557.
Crossref
Crossref
Eva Polverino & Javier Perez-Miranda. 2018. Bronchiectasis. Bronchiectasis
312
330
.
Glenn E. Dale, Atef Halabi, Marc Petersen-Sylla, Achim Wach & Christian Zwingelstein. (2018) Pharmacokinetics, Tolerability, and Safety of Murepavadin, a Novel Antipseudomonal Antibiotic, in Subjects with Mild, Moderate, or Severe Renal Function Impairment. Antimicrobial Agents and Chemotherapy 62:9.
Crossref
Crossref
Helio S Sader, Robert K Flamm, Glenn E Dale, Paul R Rhomberg & Mariana Castanheira. (2018) Murepavadin activity tested against contemporary (2016–17) clinical isolates of XDR Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 73:9, pages 2400-2404.
Crossref
Crossref